These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9718527)

  • 1. Slippage in the NHS breast screening programme: an assessment of whether a three year screening round is being achieved.
    Faux AM; Lawrence GM; Wheaton ME; Wallis MG; Jeffery CL; Griffiths RK
    J Med Screen; 1998; 5(2):88-91. PubMed ID: 9718527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interval breast cancers in the NHS Breast Screening Programme: does the current definition exclude too many?
    Faux AM; Richardson DC; Lawrence GM; Wheaton ME; Wallis MG
    J Med Screen; 1997; 4(3):169-73. PubMed ID: 9368875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammography screening in the county of Fyn. November 1993-December 1999.
    Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
    APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening outcomes in women over age 70 who self-refer in the NHSBSP in England.
    Bennett RL; Moss SM
    J Med Screen; 2011; 18(2):91-5. PubMed ID: 21852702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coverage in the National Health Service Breast Screening Programme, 1996-2005: correcting for the first invitation of women between 50 and 52 years.
    Bennett RL; Blanks RG; Moss SM
    J Public Health (Oxf); 2008 Jun; 30(2):167-70. PubMed ID: 18339650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of the prevalent round of the breast screening programme in south east Thames, 1988-1993: achievement of quality standards and population impact.
    Garvican L; Littlejohns P
    J Med Screen; 1996; 3(3):123-8. PubMed ID: 8946306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results from the UK NHS Breast Screening Programme 2000-05.
    Bennett RL; Blanks RG; Patnick J; Moss SM
    J Med Screen; 2007; 14(4):200-4. PubMed ID: 18078565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the population dose to the UK population from the National Health Service Breast Screening Programme.
    Faulkner K; Wallis MG; Neilson F; Whitaker CJ
    Radiat Prot Dosimetry; 2008; 129(1-3):184-90. PubMed ID: 18483008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for breast cancer in England: past and future.
    Advisory Committee on Breast Cancer Screening
    J Med Screen; 2006; 13(2):59-61. PubMed ID: 16792825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once is enough--why some women do not continue to participate in a breast cancer screening programme.
    Elwood M; McNoe B; Smith T; Bandaranayake M; Doyle TC
    N Z Med J; 1998 May; 111(1066):180-3. PubMed ID: 9640316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effectiveness of population-based breast cancer screening programme].
    Szynglarewicz B; Matkowski R; Kasprzak P; Kotowska J; Forgacz J; Pudełko M; Kornafel J
    Pol Merkur Lekarski; 2009 Feb; 26(152):117-20. PubMed ID: 19388515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The West Midlands breast cancer screening status algorithm - methodology and use as an audit tool.
    Lawrence G; Kearins O; O'Sullivan E; Tappenden N; Wallis M; Walton J
    J Med Screen; 2005; 12(4):179-84. PubMed ID: 16417694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420).
    French DP; Astley S; Brentnall AR; Cuzick J; Dobrashian R; Duffy SW; Gorman LS; Harkness EF; Harrison F; Harvie M; Howell A; Jerrison A; Machin M; Maxwell AJ; McWilliams L; Payne K; Qureshi N; Ruane H; Sampson S; Stavrinos P; Thorpe E; Ulph F; van Staa T; Woof V; Evans DG
    BMC Cancer; 2020 Jun; 20(1):570. PubMed ID: 32552763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of prognostic and socio-economic factors in screen-detected and symptomatic cases of breast cancer.
    Garvican L; Littlejohns P
    Public Health; 1998 Jan; 112(1):15-20. PubMed ID: 9490883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal screening mammography reading volumes; evidence from real life in the East Midlands region of the NHS Breast Screening Programme.
    Cornford E; Reed J; Murphy A; Bennett R; Evans A
    Clin Radiol; 2011 Feb; 66(2):103-7. PubMed ID: 21216324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First report of introducing population-based breast cancer screening in Poland: experience of the 3-million population region of Lower Silesia.
    Matkowski R; Szynglarewicz B
    Cancer Epidemiol; 2011 Dec; 35(6):e111-5. PubMed ID: 21840281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results from the NHS breast screening programme 1990-1993.
    Moss SM; Michel M; Patnick J; Johns L; Blanks R; Chamberlain J
    J Med Screen; 1995; 2(4):186-90. PubMed ID: 8719146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results from 10 years of breast screening in Wales.
    Fielder H; Rogers C; Gower-Thomas K; Monypenny I; Dallimore N; Brook D; Greening S
    J Med Screen; 2001; 8(1):21-3. PubMed ID: 11373845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.